China / 5 Top Trends in Healthcare & Biopharma in 2020
2020 has been eventful – perhaps the understatement of the year – but despite the novel coronavirus being…
Karen Xi |
Editor
Articles: Karen Xi
APAC / Prestige & HH&L IPO News; Cold Chain Vaccine Challenges; Moderna Looks to CMOs
The latest pharma news from the Asia-Pacific region, including upcoming IPOs for Prestige Biopharma and HH&L…
Europe / Will New Pharmaceutical Strategy Prove to be a Game-Changer?
On 25 November 2020, the European Commission adopted a Pharmaceutical Strategy for Europe with the stated aim of…
China / Sinopharm Vaccine Approval; Online Healthcare Boom; 51% Drug Price Cuts
The latest from Chinese pharma, including domestic regulatory approval for Sinopharm’s COVID-19 vaccine, how…
USA / The Long Read: Innovation, Access & Affordability
A Tale of Two Americas The US stands as the biopharma innovation champion of the world, a global leader on nearly…
Global / PharmaBoardroom's Top Women Leaders 2020
While great strides in gender diversity has been made within healthcare boardrooms and leadership teams globally,…
Cell & Gene Therapy / CRISPR-Cas9 Nobel Prize Pioneers in Profile
On 7 October 2020, the 2020 Nobel Prize in Chemistry was jointly awarded to Emmanuelle Charpentier and Jennifer A.…
Japan / Taiho Pharmaceutical: An Oral Chemotherapy Pioneer
Japanese pharma companies are already far lower-profile than their occidental counterparts but an even lesser-known…
China / Pharma Share Price Hit; Pfizer-LianBio Linkup; Novo’s New Chatbot
The latest from Chinese pharma, including a drop in share prices for Chinese vaccine firms in the wake of…
Asia-Pacific / World’s Largest Trade Deal’s Pharma Impact Too Early to Tell
On 15 November 2020, the world’s largest trade deal in terms of GDP – the Regional Comprehensive Economic…
USA / Rare Disease Strategies in a Booming Market
Rare disease – defined in the US as a disease with a maximum patient population of 200,000 – is perhaps the…
USA / Novartis Oncology: Leaning into Change
With a series of reorganization initiatives, new leaders at the helm and exciting acquisitions, Novartis Oncology…